INIS
patients
100%
india
52%
comparative evaluations
41%
reviews
37%
control
32%
quality of life
30%
symptoms
28%
therapy
28%
communities
28%
people
27%
nervous system diseases
24%
interventions
20%
assessments
18%
maintenance
17%
charts
12%
performance
12%
populations
11%
stimuli
11%
size
11%
sleep
11%
education
10%
side effects
10%
errors
10%
levels
10%
hospitals
9%
attitudes
9%
surveys
9%
adults
9%
risks
8%
safety
8%
drugs
8%
psychoses
8%
prediction
8%
lifetime
8%
antidepressants
8%
males
7%
tools
7%
switches
7%
data
6%
erbium phosphides
6%
reduction
6%
birth
5%
trains
5%
information
5%
females
5%
Medicine and Dentistry
Prospective Study
17%
Assertive Community Treatment
17%
Mental Health
13%
Dihydrotachysterol
12%
Disease
11%
Randomized Controlled Trial
9%
Electroconvulsive Therapy
8%
Lifespan
8%
Health Survey
8%
Meta-Analysis
8%
Yoga
8%
Systematic Review
8%
Treatment-Resistant Schizophrenia
8%
Bipolar I Disorder
8%
Melancholia
8%
Consumer
8%
Cycloserine
8%
Ethambutol
8%
Multidrug Resistant Tuberculosis
8%
Neuropathy
8%
Antidepressant
8%
Adverse Event
7%
Prevalence
6%
Depression
5%
Hazard Ratio
5%
Placebo
5%
Hypomania
5%
Ethionamide
5%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
20%
Clozapine
12%
Antipsychotic
11%
Dihydrotachysterol
9%
Treatment-Resistant Schizophrenia
8%
Cycloserine
8%
Bipolar I Disorder
8%
Prospective Study
8%
Ethambutol
8%
Melancholia
8%
Antidepressant
8%
Polypharmacy
8%
Multi-Drug-Resistant Tuberculosis
8%
Adverse Event
8%
Neuropathy
8%
Remission
6%
Ethionamide
5%
Hypomania
5%
Placebo
5%